Nurofen fined $1 million for false claims

Print Friendly, PDF & Email
Share to Google Classroom

The makers of Nurofen have been fined over $1million in New Zealand for misleading claims.
The claims were around the marketing of Nurofen Migraine Pain, Nurofen Tension Headache, Nurofen Period Pain and Nurofen Back Pain.
The Commerce Commission alleged people paid up to an extra $7 a packet believing these products were tailored to a particular pain in a particular part of the body.
In fact, each product contained exactly the same active ingredient, 342 mg ibuprofen lysine, and all worked identically.
Commerce Commission chairman Dr Mark Berry said the packaging of these products and the company website gave consumers the impression the products were targeted to relieve a specific kind of pain.
The company was also prosecuted in Australia.

6 Responses

  1. I think it is really disappointing that they have done this because it is easier just to tell the truth rather then keep it a secret, and to make customers believe in it

Leave a Reply

Your email address will not be published. Required fields are marked *

The Comedy Wildlife Photography Awards are back, and this year...
Twenty-six-year-old Kalpana Balan from India, has clinched a coveted spot...
At the International Association of Amusement Parks and Attractions expo...
In a delightful twist of literary history, a library book,...

World & National News

In a departure from recent trends, Walt Disney Studios is...
Hands down, we all love school holidays, that’s a given....
Imagine living in a super pretty town and finding out...
The Wellington Phoenix are having a fantastic time in the...